6OOA
Human CYP3A4 bound to a drug substrate
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.2 |
Synchrotron site | ALS |
Beamline | 5.0.2 |
Temperature [K] | 77 |
Detector technology | PIXEL |
Collection date | 2018-04-13 |
Detector | DECTRIS PILATUS3 6M |
Wavelength(s) | 1.0 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 76.499, 101.590, 125.529 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 65.325 - 2.520 |
R-factor | 0.198 |
Rwork | 0.195 |
R-free | 0.25230 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5vcc |
RMSD bond length | 0.009 |
RMSD bond angle | 1.159 |
Data reduction software | iMOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX ((1.11.1_2575)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 78.970 | 2.660 |
High resolution limit [Å] | 2.520 | 2.520 |
Rmerge | 0.074 | 1.500 |
Rpim | 0.034 | 0.691 |
Number of reflections | 16915 | 2438 |
<I/σ(I)> | 11.1 | 1.2 |
Completeness [%] | 100.0 | 100 |
Redundancy | 5.6 | 5.6 |
CC(1/2) | 0.999 | 0.366 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7 | 298 | PEG 3350 |